Chemed Corporation $CHE Shares Sold by Kennedy Capital Management LLC

Kennedy Capital Management LLC reduced its stake in Chemed Corporation (NYSE:CHE) by 12.7% during the 4th quarter, Holdings Channel reports. The fund owned 16,669 shares of the company’s stock after selling 2,421 shares during the quarter. Kennedy Capital Management LLC’s holdings in Chemed were worth $7,132,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. SG Americas Securities LLC increased its holdings in Chemed by 773.5% in the fourth quarter. SG Americas Securities LLC now owns 26,466 shares of the company’s stock valued at $11,324,000 after buying an additional 23,436 shares during the last quarter. Intech Investment Management LLC purchased a new position in Chemed in the third quarter valued at $1,429,000. Bahl & Gaynor Inc. increased its holdings in Chemed by 15.4% in the third quarter. Bahl & Gaynor Inc. now owns 20,042 shares of the company’s stock valued at $8,974,000 after buying an additional 2,673 shares during the last quarter. Abacus FCF Advisors LLC purchased a new position in Chemed in the fourth quarter valued at $5,935,000. Finally, BNP Paribas Financial Markets increased its holdings in Chemed by 14.5% in the fourth quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company’s stock valued at $14,985,000 after buying an additional 4,430 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Stock Performance

Shares of CHE stock opened at $423.37 on Tuesday. The stock’s 50-day moving average is $416.13 and its two-hundred day moving average is $424.30. The firm has a market cap of $5.62 billion, a price-to-earnings ratio of 23.07, a PEG ratio of 1.57 and a beta of 0.54. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $562.77. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.30 by $0.35. The company had revenue of $657.51 million for the quarter, compared to analyst estimates of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The business’s quarterly revenue was up 1.6% compared to the same quarter last year. During the same quarter last year, the company posted $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Analysts predict that Chemed Corporation will post 22.3 earnings per share for the current year.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th will be issued a dividend of $0.60 per share. The ex-dividend date of this dividend is Thursday, May 28th. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. Chemed’s dividend payout ratio (DPR) is presently 13.08%.

Insider Activity

In other Chemed news, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the transaction, the director owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the transaction, the chief executive officer directly owned 90,219 shares in the company, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 3.33% of the company’s stock.

Wall Street Analysts Forecast Growth

CHE has been the topic of several recent analyst reports. Royal Bank Of Canada increased their target price on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. Oppenheimer dropped their target price on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Wall Street Zen lowered Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Finally, Weiss Ratings raised Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Two investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, Chemed has an average rating of “Hold” and an average price target of $501.50.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.